spacer
home > ict > spring 2019 > enhancing the patient experience
PUBLICATIONS
International Clinical Trials

Enhancing the Patient Experience

The opportunities to strengthen patient engagement across all phases of clinical development have never been greater. We can now apply technology in creative ways to collect meaningful data from patients without increasing their burden as trial participants.

At the same time, empowered patients have high expectations of their health-related experiences in general, with clinical trial participation being no exception. As savvy consumers, patients expect technology to be both easy and enjoyable to use. Therefore, study sponsors and CROs should look to take advantage of the latest tools to ensure that a patient’s involvement meets their expectations, fits into their daily lives to the greatest extent possible, and is, overall, a rewarding experience.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
James Munz is a product expert who has been solving business problems with cutting edge analytical and technical solutions for close to 20 years. As Vice President of eCOA Product Management, James is responsible for building and executing ERT’s market-driven strategy for the eCOA product line. Prior to ERT, he was Vice President of Product at Opera Solutions where he was responsible for the development of a Big Data analytics platform used across supply chain, financial services, marketing, healthcare, and telecommunications industries. Additionally, he led one of the first products to leverage the Amazon Cloud.

Chris Watson PhD is a Product Strategist with 20 years’ experience in the delivery of business and consumer-based solutions, the last 10 of which have been within the clinical technology industry. He has extensive knowledge of product and software development processes and is responsible for implementing the product strategy for ERT’s digital patient business. Chris earned his PhD in Behavioural Neurosciences from the University of Nottingham, UK, and a BSc in pharmacology and toxicology, with honours, from the University of Bradford, UK.
spacer
James Munz
spacer
spacer
spacer
Chris Watson PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new market reference added to Safe’n’Sound®, our passive safety device platform

Safe’n’Sound® is on the market in Europe with a newly registered injectable medication. The commercial launch of HULIO™ (Adalimumab Biosimilar) was initiated in selected European markets on October 19,2018. Hulio™, developed by Fujifilm Kyowa Kirin Biologics Co., Ltd. and marketed in the European Union by Mylan N.V. is approved as a biosimilar for the same indications as the reference product, Humira®.
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement